Segment Information - Schedule of Reportable Segments (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Schedule of Reportable Segments [Line Items] | ||||||
| Revenue from civil applications segment | $ 149 | $ 143 | $ 149 | $ 143 | ||
| Cost of revenues from civil applications segment | (91) | (55) | (124) | (63) | ||
| Gross profit | 58 | 88 | 25 | 80 | ||
| Research and development expenses | (32) | (24) | (61) | (45) | ||
| Operating loss | (928) | (250) | (1,441) | (538) | ||
| Net loss | (726) | $ (921) | (269) | $ (279) | (1,647) | (548) |
| Chief Executive Officer [Member] | Reportable Segments [Member] | ||||||
| Schedule of Reportable Segments [Line Items] | ||||||
| Revenue from civil applications segment | 149 | 127 | 149 | 127 | ||
| Cost of revenues from civil applications segment | (91) | (55) | (124) | (63) | ||
| Gross profit | 58 | 72 | 25 | 64 | ||
| Other revenues | 16 | 16 | ||||
| Research and development expenses | (32) | (24) | (61) | (45) | ||
| Depreciation | (2) | (4) | (4) | (9) | ||
| Professional services | (650) | (181) | (948) | (357) | ||
| Share base compensation | (168) | (67) | (263) | (77) | ||
| Other general and administrative expenses | (134) | (62) | (190) | (130) | ||
| Operating loss | (928) | (250) | (1,441) | (538) | ||
| Interest expenses | (13) | (41) | (222) | (71) | ||
| Interest income | 215 | 32 | 16 | 71 | ||
| Other expenses | (10) | (10) | ||||
| Net loss | $ (726) | $ (269) | $ (1,647) | $ (548) | ||
| X | ||||||||||
- Definition Amount of other revenue. No definition available.
|
| X | ||||||||||
- Definition Amount, after tax, of expense for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|